Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
of the leading Engineering Schools in the UK. We are a world-class research-intensive university, delivering high-quality teaching and playing a key role in the economic, social, and cultural development
-
with an excellent level of service and ensure that they are effectively supported throughout their programme. This will include acting as front-line support for student queries in a range of locations on
-
, the flagship programme of the Newcastle Health Research Partnership. In addition to the Newcastle PSRC, the postholder will have an academic home at the Newcastle University Population Health Sciences Institute
-
high levels of accuracy. Education Administrators provide professional administrative services and leadership to ensure the smooth and effective running of the School’s taught programmes. Working as part
-
, Senior and Personal Tutors, Degree Programme Directors and Professional Support colleagues), to provide a local, comprehensive and professional point of contact for both incoming and registered students
-
through data. It delivers a flexible rolling programme of collaborative projects that focus on a specific business challenge or opportunity and transfers practical data skills into the workforce. Using
-
Patterson Foundation and is aimed at generating pilot data to support further funding applications. We are looking for a motivated researcher to join our group to perform transcriptomics and functional assays
-
or surface plasmon resonance), mass spectrometry, analysis of protein structures or enzymology • Be able to demonstrate a high level of expertise and success in the previous research areas, e.g. by
-
acquire new skills Detailed subject knowledge in high-resolution liquid chromatography mass spectrometry, microbial metabolomics and specialized metabolites. Likelihood of advanced skills directly related
-
new drug targets that are specifically lethal to tumour cells lacking SMARCB1. The ultimate goal is to generate high-quality evidence to support the inclusion of novel therapies in clinical trials, and